Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
about
Are Escherichia coli Pathotypes Still Relevant in the Era of Whole-Genome Sequencing?Towards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coliCharacterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies.Toxicity and immunogenicity of Enterotoxigenic Escherichia coli heat-labile and heat-stable toxoid fusion 3xSTa(A14Q)-LT(S63K/R192G/L211A) in a murine model.Modified heat-stable toxins (hSTa) of enterotoxigenic Escherichia coli lose toxicity but display antigenicity after being genetically fused to heat-labile toxoid LT(R192G).Designing vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli.Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin.Recent advances in understanding enteric pathogenic Escherichia coli.A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building.The molecular basis for control of ETEC enterotoxin expression in response to environment and hostGenetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.Generation of high-titer of neutralizing polyclonal antibodies against heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coliIdentification and antimicrobial resistance prevalence of pathogenic Escherichia coli strains from treated wastewater effluents in Eastern Cape, South Africa.Multifaceted interactions of bacterial toxins with the gastrointestinal mucosa.Recent progress toward an enterotoxigenic Escherichia coli vaccine.Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.Gastrointestinal infections in the setting of natural disasters.Construction and evaluation of a fluorescence-based live attenuated Escherichia coli delivery system for generating oral vaccine candidate.Current pathogenic Escherichia coli foodborne outbreak cases and therapy development.Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.Design and characterization of a chimeric multiepitope construct containing CfaB, heat-stable toxoid, CssA, CssB, and heat-labile toxin subunit B of enterotoxigenic Escherichia coli: a bioinformatic approach.A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.Bacterial outer membrane vesicles: New insights and applications.The Critical Role of Zinc in a New Murine Model of Enterotoxigenic E. coli (ETEC) Diarrhea.Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants.
P2860
Q28077683-4F49A8CC-E48B-429E-92A3-45946ACE5100Q30277331-94C47BF2-FC49-4CBA-8210-37640F400101Q30409778-FA82DE9A-7C8B-48D2-B414-9205FC66A6D6Q30416787-942B3C5A-7D36-4B99-8B38-A2766A47FACEQ30429806-09B24909-C070-4742-B2BF-0E0D75E782EEQ33813634-52A03C0E-C5C1-437F-8742-DF17B674E646Q33899693-307B737F-3027-48E9-AD70-FD756B06765DQ34375210-551206A1-C183-4DB8-99B5-389C42996C81Q34787042-D9C269C0-80B8-4904-AC26-8D23A8C5B6E5Q34876417-ECBA6095-47A0-4C80-9209-B3ACE6712956Q35213355-6CCE9E10-2926-4BC3-AC11-5A312FE1F4ECQ35998767-F7AB2547-DF00-4259-9D8C-58DA8DE0524BQ36269155-A495106E-9028-4685-A5B2-B9970F30ADFAQ36618822-6916E54B-44A0-49CA-B511-6EDA2221FB49Q37907307-8C66EA29-C86F-458C-BB50-44E85418BF5BQ38006998-944B199E-1262-48B2-BDAD-2211B4BA63E5Q38032878-2C990580-B06A-445F-948C-0B6049C8C7A0Q38419777-9F4C5B32-D10B-4D76-A600-AAE84B9CB2B8Q39063059-141B8F81-D361-40FA-BFE0-E2DD334EA0BAQ39361401-92B331E0-6A27-4AE3-B00C-277B1C8521B7Q40375701-31AED7D2-676A-4BDD-BD93-CAAA3D4CBC30Q43472318-5CCE0CCF-56A8-49E6-8241-A2E585F2CF6EQ47753043-EBA76FEF-6625-4B62-82FA-463AF67F8A28Q49496755-D31893A1-3FFB-4576-A5F8-DD0359791737Q52691340-729D3F31-1050-48E8-9F11-525E31FFC81BQ54368487-2A5991EC-630C-4794-AB45-50A8D05460BD
P2860
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
@en
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.
@nl
type
label
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
@en
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.
@nl
prefLabel
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
@en
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.
@nl
P2093
P2860
P356
P1476
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
@en
P2093
James Nataro
Pål Puntervoll
P2860
P304
P356
10.1128/IAI.01397-09
P407
P577
2010-03-15T00:00:00Z